Abstract
Differentiation between progression of disease (POD) and treatment-related changes (TRCs) in brain tumors remains challenging. Both POD and TRCs can lead to mass effects, perilesional edema, and contrast enhancement in conventional MRI, which presents a major problem in clinical decision-making ([1
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Paper Title
Journal
Date
